Literature DB >> 29416859

Applying realistic medicine to intrathecal opioid utilisation in Scotland: do we have a standardised approach?

Robert Hart1, Gordon Burns1, Susan Smith1.   

Abstract

Intrathecal opioids (ITOs) are commonly administered as part of a multimodal anaesthetic strategy for a variety of surgical procedures. The evolution of laparoscopic surgical techniques has seen the popularity of ITOs increase as they are effective, well tolerated and lack the cardiovascular side effects associated with epidural infusions. The risk of delayed respiratory depression remains a concern; therefore, high-quality post-operative monitoring is vital. The evidence regarding the practicalities of ITO administration such as opioid dose, type, side effect prevalence and ideal post-operative care arrangements are sparse. As such, a variety of clinical opinion has been generated. In order to quantify this variation within Scotland, we devised a short telephone questionnaire regarding ITO utilisation. We contacted 16 acute surgical sites. Of these, 14 confirmed regular utilisation of ITOs. Our survey demonstrated significant variability in practice. Both diamorphine and morphine are utilised, but no centre could provide a reason to justify the choice of one over the other. The commonly administered dose range for both agents ranged between 100 and 1100 µg. Most centres employed post-operative monitoring geared towards the detection of delayed respiratory depression but this was not unanimous. Each centre had a variation on what observations nursing staff were expected to complete in the post-operative period. Itch and nausea were not encountered frequently. Two centres experienced at least one episode of delayed respiratory depression which was detected and treated with no patient harm. In the report to the Scottish Government, 'Realistic Medicine', by the Chief Medical Officer, the need to reduce unnecessary variation in practice and outcomes is highlighted. We believe that a national sprint audit would gather sufficient prospective data to further determine whether a correlation exists between side effect profile and ITO utilisation practice. We hope this would help form a consensus and guide a standardised approach.

Entities:  

Keywords:  Intrathecal opioids; acute pain; delayed respiratory depression; post-operative analgesia; practice variation and outcome; realistic medicine

Year:  2017        PMID: 29416859      PMCID: PMC5788109          DOI: 10.1177/2049463717717124

Source DB:  PubMed          Journal:  Br J Pain        ISSN: 2049-4637


  11 in total

Review 1.  Opioids, ventilation and acute pain management.

Authors:  P E Macintyre; J A Loadsman; D A Scott
Journal:  Anaesth Intensive Care       Date:  2011-07       Impact factor: 1.669

2.  Intrathecal opioids, potency and lipophilicity.

Authors:  Henry J McQuay; Ann F Sullivan; Karen Smallman; Anthony H Dickenson
Journal:  Pain       Date:  1989-01       Impact factor: 6.961

3.  Practice Guidelines for the Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration: An Updated Report by the American Society of Anesthesiologists Task Force on Neuraxial Opioids and the American Society of Regional Anesthesia and Pain Medicine.

Authors: 
Journal:  Anesthesiology       Date:  2016-03       Impact factor: 7.892

4.  Intrathecal morphine is superior to intravenous PCA in patients undergoing minimally invasive cardiac surgery.

Authors:  Chirojit Mukherjee; Eva Koch; Joergen Banusch; Markus Scholz; Udo X Kaisers; Joerg Ender
Journal:  Ann Card Anaesth       Date:  2012 Apr-Jun

5.  Opioids added to local anesthetics for single-shot intrathecal anesthesia in patients undergoing minor surgery: a meta-analysis of randomized trials.

Authors:  Daniel M Pöpping; Nadia Elia; Emmanuel Marret; Manuel Wenk; Martin R Tramèr
Journal:  Pain       Date:  2012-01-09       Impact factor: 6.961

6.  The safety and efficacy of intrathecal opioid analgesia for acute postoperative pain: seven years' experience with 5969 surgical patients at Indiana University Hospital.

Authors:  K H Gwirtz; J V Young; R S Byers; C Alley; K Levin; S G Walker; R K Stoelting
Journal:  Anesth Analg       Date:  1999-03       Impact factor: 5.108

7.  Dose-response pharmacology of intrathecal morphine in human volunteers.

Authors:  P L Bailey; S Rhondeau; P G Schafer; J K Lu; B S Timmins; W Foster; N L Pace; T H Stanley
Journal:  Anesthesiology       Date:  1993-07       Impact factor: 7.892

Review 8.  Benefit and risk of intrathecal morphine without local anaesthetic in patients undergoing major surgery: meta-analysis of randomized trials.

Authors:  N Meylan; N Elia; C Lysakowski; M R Tramèr
Journal:  Br J Anaesth       Date:  2009-02       Impact factor: 9.166

9.  A change in practice from epidural to intrathecal morphine analgesia for hepato-pancreato-biliary surgery.

Authors:  Magdalena Sakowska; Elizabeth Docherty; David Linscott; Saxon Connor
Journal:  World J Surg       Date:  2009-09       Impact factor: 3.352

Review 10.  Risks and side-effects of intrathecal morphine combined with spinal anaesthesia: a meta-analysis.

Authors:  M Gehling; M Tryba
Journal:  Anaesthesia       Date:  2009-06       Impact factor: 6.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.